Liver cancer, a large proportion of which is hepatocellularcarcinoma (HCC), is diagnosed in more than700000 people each year worldwide. Liver canceris particularl
AIM To investigate serum PC-594 fatty acid levels asa potential biomarker in North American pancreaticcancer (PaC) patients, and to compare its performanceto CA19